Total planned funding: $271,695,873
Allocations
Countries/Regions
Eswatini | $271,695,873 |
Organizational Types
Private Contractor | $62,513,182 |
University | $61,066,610 |
NGO | $53,462,918 |
Unknown | $39,955,064 |
Own Agency | $33,500,084 |
Host Country Government Agency | $11,473,308 |
FBO | $6,188,454 |
Multi-lateral Agency | $2,033,840 |
Implementing Agency | $759,600 |
Other USG Agency | $742,813 |
Program Areas
Care | $84,478,747 |
Prevention | $53,285,222 |
Treatment | $51,808,907 |
Governance and Systems | $37,683,278 |
Management and Operations | $22,354,672 |
Testing | $22,085,047 |
Budget Codes
HTXS: Treatment: Adult Treatment | $41,125,260 |
HBHC: Care: Adult Care and Support | $37,209,823 |
HKID: Care: Orphans and Vulnerable Children | $24,017,895 |
HVMS: Management and Operations | $22,354,672 |
HVCT: Testing: HIV Testing and Counseling | $22,085,047 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,047,218 |
HVTB: Care: TB/HIV | $16,172,029 |
OHSS: Health Systems Strengthening | $15,974,007 |
HVSI: Strategic Information | $14,979,845 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,905,867 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,540,987 |
HVOP: Sexual Prevention: Other Sexual Prevention | $10,454,150 |
PDCS: Care: Pediatric Care and Support | $7,079,000 |
HLAB: Laboratory Infrastructure | $6,729,426 |
PDTX: Treatment: Pediatric Treatment | $5,412,028 |
HTXD: Treatment: ARV Drugs | $5,271,619 |
HMBL: Biomedical Prevention: Blood Safety | $2,337,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$53,704,075
Countries/Regions
Not Available:
$35,556,078
Countries/Regions
Pact, Inc.:
$31,256,301
Countries/Regions
USG Aggregated Agencies:
$19,851,332
Countries/Regions